SB-203853

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSB-203853

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionRNA synthesis inhibitors

TargetsUpdating

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A

Related LinksN/A